Bunge Global vs CHS
Bunge Global is the larger business, with $70.33bn of revenue in fiscal 2025 against $35.46bn for CHS (2.0 times as much). Bunge Global grew faster (32.4% against -9.7%). CHS kept more of each dollar of sales as profit: a net margin of 1.7% against 1.2%.
| Latest fiscal year | Bunge GlobalBG, 2025 | CHSCHSCL, 2025 |
|---|---|---|
| Revenue | $70.33bn | $35.46bn |
| Revenue growth | 32.4% | -9.7% |
| Net income | $816m | $598m |
| Operating margin | — | — |
| Net margin | 1.2% | 1.7% |
| Return on equity | 6.3% | 5.5% |
| Free cash flow | −$879m | −$92.8m |
| Cash | $1.14bn | $328m |
| Total debt | $14.05bn | $1.84bn |
| Debt to equity | 88.3% | — |
| Dividend per share | $2.80 | — |
| Dividend yield | 3.0% | — |
| Share buybacks | $551m | — |
| Employees | 34,000 | 10,683 |
| Market value | $18.28bn | — |
| Price vs our value range | — | — |
| Moat score | — | 22 (Weak) |
| Insider trades, 12 months | 2 buys, 3 sales | 0 buys, 0 sales |